Revance Therapeutics Inc. (RVNC)
3.65
0.01 (0.27%)
At close: Jan 28, 2025, 2:56 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| PE Ratio | -2.3 | -3.77 | -3.84 | -5.83 | -4.52 | -5.11 | -8.92 | -6.52 | -11.31 | -5.22 | -9.08 | -3.31 | -4.3 |
| PS Ratio | 3.18 | 10.13 | 14.16 | 107.27 | 1.71K | 195.26 | 4.11K | 1.94K | 2.77K | 857.68 | 772.18 | 268.75 | 345.95 |
| PB Ratio | -4.91 | 106.53 | 16.09 | 4.39 | 3.13 | 5.00 | 4.00 | 3.29 | 3.28 | 1.86 | -3.02 | -0.89 | -1.24 |
| P/FCF Ratio | -3.33 | -6.2 | -4.6 | -9 | -6.45 | -6.54 | -10.98 | -9.19 | -14.09 | -5.29 | -8.78 | -4.91 | -6.75 |
| P/OCF Ratio | -3.43 | -6.94 | -4.97 | -9.21 | -6.64 | -6.98 | -11.29 | -9.73 | -14.93 | -5.96 | -9.98 | -4.95 | -6.78 |
| OCF/S Ratio | -0.93 | -1.46 | -2.85 | -11.65 | -257.05 | -27.96 | -363.9 | -199.42 | -185.56 | -143.79 | -77.4 | -54.27 | -51.01 |
| Debt / Equity Ratio | -3.16 | 33.21 | 4.74 | 0.57 | 0.13 | n/a | 0.01 | 0.03 | 0.03 | 0.02 | -0.16 | -0.49 | -0.44 |
| Quick Ratio | 3.29 | 4.71 | 3.51 | 7.29 | 7.24 | 6.50 | 13.65 | 9.76 | 21.00 | 16.76 | 0.09 | 0.04 | 3.40 |
| Current Ratio | 3.80 | 4.95 | 3.66 | 7.38 | 7.24 | 6.50 | 13.65 | 9.81 | 21.10 | 16.87 | 0.10 | 0.05 | 3.40 |
| Asset Turnover | 0.49 | 0.23 | 0.15 | 0.02 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.05 | 0.01 |
| Interest Coverage | -16.37 | -16.52 | -43.79 | -18.03 | n/a | -3.24K | -263.51 | -81.53 | -60.77 | -4.88 | -2.52 | -1.49 | -1.56 |
| Return on Equity (ROE) | 2.14 | -28.29 | -4.19 | -0.75 | -0.69 | -0.98 | -0.45 | -0.5 | -0.29 | -0.36 | 0.33 | 0.27 | 0.29 |
| Return on Assets (ROA) | -0.68 | -0.61 | -0.54 | -0.39 | -0.46 | -0.63 | -0.41 | -0.44 | -0.27 | -0.33 | -2.32 | -4.34 | -1.12 |
| Return on Capital (ROIC) | -0.81 | -0.54 | -0.59 | -0.41 | -0.55 | -0.73 | -0.44 | -0.48 | -0.27 | -0.29 | 1.53 | 0.41 | -0.89 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 34.98% | 61.03% | 69.91% | 68.88% | -24.81K% | -2.38K% | 100.00% | 100.00% | -565% | 100.00% | 100.00% | 100.00% | 99.10% |
| Net Profit Margin | -138.43% | -268.87% | -368.68% | -1.84K% | -37.82K% | -3.82K% | -46.03K% | -29.76K% | -24.49K% | -16.43K% | -8.50K% | -8.13K% | -8.05K% |
| Pretax Profit Margin | -138.3% | -268.34% | -361.59% | -1.86K% | -38.60K% | -3.74K% | -46.03K% | -29.76K% | -24.49K% | -16.43K% | -8.50K% | -8.13K% | -8.05K% |
| Operating Profit Margin | -135.35% | -205.31% | -353.06% | -1.78K% | -39.82K% | -3.82K% | -45.96K% | -29.41K% | -24.11K% | -13.59K% | -6.20K% | -6.02K% | -4.98K% |
| FCF Margin | -95.48% | -163.36% | -307.99% | -1.19K% | -26.49K% | -2.99K% | -37.39K% | -21.10K% | -19.67K% | -16.20K% | -8.79K% | -5.47K% | -5.13K% |
| EBITDA Margin | -124.18% | -230.47% | -328.01% | -1.69K% | -37.90K% | -3.70K% | -45.29K% | -28.91K% | -23.43K% | -13.05K% | -5.74K% | -3.84K% | -4.50K% |